Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW +0.53% inched 0.62% higher to $122.75 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.75% falling 0.13% to 4,514.07 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.09% falling 0.20% to 35,031.07. This was the stock's fifth consecutive day of gains. Edwards Lifesciences Corp. hit a new 52-week high, surpassing its previous peak of $122.12, which the company achieved on September 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT +2.36% rose 0.45% to $135.17, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX +0.35% rose 0.91% to $45.51, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI -1.40% rose 26.23% to $260.00. Trading volume (1.7 M) remained 432,666 below its 50-day average volume of 2.1 M.